109 related articles for article (PubMed ID: 22428765)
1. Abnormal cardiomarkers in leukemia patients treated with allogeneic hematopoietic stem cell transplantation.
Roziakova L; Bojtarova E; Mistrik M; Krajcovicova I; Mladosievicova B
Bratisl Lek Listy; 2012; 113(3):159-62. PubMed ID: 22428765
[TBL] [Abstract][Full Text] [Related]
2. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation.
Roziakova L; Bojtarova E; Mistrik M; Dubrava J; Gergel J; Lenkova N; Mladosievicova B
J Exp Clin Cancer Res; 2012 Feb; 31(1):13. PubMed ID: 22321767
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
4. Can we predict clinical cardiotoxicity with cardiac biomarkers in patients after haematopoietic stem cell transplantation?
Roziakova L; Mistrik M; Batorova A; Kruzliak P; Bojtarova E; Dubrava J; Gergel J; Mladosievicova B
Cardiovasc Toxicol; 2015 Jul; 15(3):210-6. PubMed ID: 25287586
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular complications among hematopoietic cell transplantation survivors - the role of cardiomarkers.
Harvanová Ľ; Lábska V; Bojtárová E; Hrubiško M; Bátorová A; Dúbrava J; Gergeľ J; Mladosievičová B
Klin Onkol; 2022; 35(6):454-460. PubMed ID: 36513512
[TBL] [Abstract][Full Text] [Related]
6. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
7. Long-term cardiac effects of treatment for childhood leukemia.
Urbanova D; Urban L; Simkova I; Danova K; Mikuskova E; Mladosievicova B
Neoplasma; 2010; 57(2):179-83. PubMed ID: 20099983
[TBL] [Abstract][Full Text] [Related]
8. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
[TBL] [Abstract][Full Text] [Related]
9. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
Dodos F; Halbsguth T; Erdmann E; Hoppe UC
Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371
[TBL] [Abstract][Full Text] [Related]
11. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
[TBL] [Abstract][Full Text] [Related]
12. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial.
Gaggin HK; Dang PV; Do LD; deFilippi CR; Christenson RH; Lewandrowski EL; Lewandrowski KB; Truong BQ; Pham VQ; Vu VH; Vu TV; Nguyen TB; Belcher AM; Femia A; Kelley C; Januzzi JL
Clin Chem; 2014 May; 60(5):758-64. PubMed ID: 24568795
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Patients with Different N-Terminal Probrain Natriuretic Peptide Levels after Hematopoietic Stem Cell Transplantation.
Se Z; Zhou H; Li H; Sun J; Zhan Q; Zeng Q; Liu Q; Xu D
Dis Markers; 2020; 2020():8839336. PubMed ID: 33133305
[TBL] [Abstract][Full Text] [Related]
14. Cardiac biomarkers are influenced by dialysis characteristics.
Sommerer C; Heckele S; Schwenger V; Katus HA; Giannitsis E; Zeier M
Clin Nephrol; 2007 Dec; 68(6):392-400. PubMed ID: 18184522
[TBL] [Abstract][Full Text] [Related]
15. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
[TBL] [Abstract][Full Text] [Related]
16. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
[TBL] [Abstract][Full Text] [Related]
17. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
[TBL] [Abstract][Full Text] [Related]
18. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
[TBL] [Abstract][Full Text] [Related]
19. Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines.
Ylänen K; Poutanen T; Savukoski T; Eerola A; Vettenranta K
Acta Paediatr; 2015 Mar; 104(3):313-9. PubMed ID: 25393922
[TBL] [Abstract][Full Text] [Related]
20. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
